Evidence map›Paper›PMID 38886740›Full record

Trial reportNutrition journal2024

Effects of DASH diet with or without time-restricted eating in the management of stage 1 primary hypertension: a randomized controlled trial.

Xiaoxin Zhou, Xiaoqian Lin, Jing Yu, Yi Yang, Hira Muzammel, Said Amissi, Valérie B Schini-Kerth, Xun Lei, Pedro A Jose, Jian Yang and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07189637 (The Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension), which is not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07189637 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension

TypeinterventionalSponsorNadide Gizem Tarakci FilizRan2025 to 2026Enrolled48ConditionsHypertensionArmsFace-to-face nutrition education, Intermittent Fasting Diet, Mediterranean Diet
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoxin ZhouResearch Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiaoqian LinResearch Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jing YuDepartment of Nutrition and Food Hygiene, School of Public Health, Chongqing Medical University, Chongqing, China.
Yi YangDepartment of Logistics Management Division, Chongqing Medical University, Chongqing, China.
Hira MuzammelTranslational CardioVascular Medicine, Faculty of Pharmacy, UR 3074, University of Strasbourg, Strasbourg, France.
Said AmissiTranslational CardioVascular Medicine, Faculty of Pharmacy, UR 3074, University of Strasbourg, Strasbourg, France.
Valérie B Schini-KerthTranslational CardioVascular Medicine, Faculty of Pharmacy, UR 3074, University of Strasbourg, Strasbourg, France.
Xun LeiResearch Center for Medicine and Social Development, Collaborative Innovation Center of Social Risks Governance in Health, School of Public Health, Chongqing Medical University, Chongqing, China.
Pedro A JoseDepartment of Medicine and Department of Physiology and Pharmacology, Division of Renal Diseases and Hypertension, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Jian YangResearch Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China. jianyang@hospital.cqmu.edu.cn.
Dan ShiDepartment of Nutrition and Food Hygiene, School of Public Health, Chongqing Medical University, Chongqing, China. danshi@cqmu.edu.cn.

Funding

National Natural Science Foundation of China 82100459National Natural Science Foundation of China 8210120502Program of Chongqing Medical University for Youth Innovation in Future Medicine W0085Scientific Research Innovation Project for Postgraduate in Chongqing CYB22227
6 · The paper itself

Abstract

backgroundTime-restricted eating (TRE), a popular form of intermittent fasting, has shown benefits for improving metabolic diseases and cardiometabolic health. However, the effect of TRE in the regulation of blood pressure in primary hypertension remains unclear.

methodsA 6-week randomized controlled trial was conducted, in which a total of 74 stage 1 primary hypertensive patients without high-risk were randomly assigned to Dietary Approaches to Stop Hypertension (DASH) group (n = 37) or DASH + TRE group (n = 37). Participants in the DASH + TRE group were instructed to consume their food within an 8-h window. Scientific research platform in We Chat application was used to track participants. The primary outcome was blood pressure. The secondary outcomes included body composition, cardiometabolic risk factors, inflammation-related parameters, urinary Na

resultsThe reduction of systolic blood pressure and diastolic blood pressure were 5.595 ± 4.072 and 5.351 ± 5.643 mm Hg in the DASH group and 8.459 ± 4.260 and 9.459 ± 4.375 mm Hg in the DASH + TRE group. DASH + TRE group improved blood pressure diurnal rhythm. Subjects in DASH + TRE group had decreased extracellular water and increased urinary Na

conclusionOur study demonstrated that 8-h TRE + DASH diet caused a greater decrease in blood pressure in stage 1 primary hypertensive patients than DASH diet. This study may provide novel insights into the benefits of lifestyle modification in the treatment of primary hypertension.

trial registrationhttps://www.chictr.org.cn/ (ChiCTR2300069393, registered on March 15, 2023).

Indexed as

Blood PressureDietary Approaches To Stop HypertensionHypertensionAdultFastingFemaleHumansMaleMiddle AgedTreatment OutcomeBlood pressurePrimary hypertensionTime-restricted eatingUrinary Na+ excretion

Identifiers

PMID38886740
PMCPMC11181626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.